Company Registration No. 11089477 (England and Wales)
SACKS OSTEOPATHY LTD
Unaudited accounts
for the year ended 31 March 2023
SACKS OSTEOPATHY LTD
Unaudited accounts
Contents
SACKS OSTEOPATHY LTD
Company Information
for the year ended 31 March 2023
Directors
Mr Stephen Sacks
Mrs Naomi Esther Katz Sacks
Company Number
11089477 (England and Wales)
Registered Office
152 Coles Green Road
London
NW2 7HD
Accountants
Jacobs & Company
152 Coles Green Road
London
NW2 7HD
SACKS OSTEOPATHY LTD
Statement of financial position
as at 31 March 2023
Intangible assets
40,000
-
Tangible assets
60,994
360
Cash at bank and in hand
165,877
136,930
Creditors: amounts falling due within one year
(47,586)
(26,499)
Net current assets
118,770
147,736
Total assets less current liabilities
219,764
148,096
Creditors: amounts falling due after more than one year
(26,311)
-
Provisions for liabilities
Net assets
184,061
148,096
Called up share capital
100
100
Profit and loss account
183,961
147,996
Shareholders' funds
184,061
148,096
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 5 December 2023 and were signed on its behalf by
Mr Stephen Sacks
Director
Company Registration No. 11089477
SACKS OSTEOPATHY LTD
Notes to the Accounts
for the year ended 31 March 2023
SACKS OSTEOPATHY LTD is a private company, limited by shares, registered in England and Wales, registration number 11089477. The registered office is 152 Coles Green Road, London, NW2 7HD.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
over the life of the lease
Motor vehicles
5 years straight line
Fixtures & fittings
5 years straight line
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
SACKS OSTEOPATHY LTD
Notes to the Accounts
for the year ended 31 March 2023
4
Intangible fixed assets
Goodwill
5
Tangible fixed assets
Land & buildings
Motor vehicles
Fixtures & fittings
Total
Cost or valuation
At cost
At cost
At cost
At 1 April 2022
1,800
-
-
1,800
Additions
13,831
55,183
1,616
70,630
At 31 March 2023
15,631
55,183
1,616
72,430
At 1 April 2022
1,440
-
-
1,440
Charge for the year
2,636
7,037
323
9,996
At 31 March 2023
4,076
7,037
323
11,436
At 31 March 2023
11,555
48,146
1,293
60,994
At 31 March 2022
360
-
-
360
Amounts falling due within one year
Accrued income and prepayments
479
-
7
Creditors: amounts falling due within one year
2023
2022
Taxes and social security
10,002
15,525
Loans from directors
25,984
-
SACKS OSTEOPATHY LTD
Notes to the Accounts
for the year ended 31 March 2023
8
Creditors: amounts falling due after more than one year
2023
2022
Obligations under finance leases and hire purchase contracts
26,311
-
9
Deferred taxation
2023
2022
Accelerated capital allowances
9,392
-
Charged to the profit and loss account
9,392
-
Provision at end of year
9,392
-
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
11
Operating lease commitments
2023
2022
At 31 March 2023 the company had the following future minimum lease payments under non-cancellable operating leases for each of the following periods:
Later than one year and not later than five years
66,000
20,000
Brought
Forward
Advance/
credit
Repaid
Carried
Forward
Interest is charged @ 2.50%. The loan was repaid on 1 April 2022.
13
Average number of employees
During the year the average number of employees was 4 (2022: 4).
